FindTrial
Sign In

Effect and mechanism of SLC9A8 in severe acute pancreatitis

Effect and mechanism of SLC9A8 in severe acute pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076433
Enrollment
Unknown
Registered
2023-10-09
Start date
2023-10-09
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis

Interventions

SAP:none
Control:none

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: SAP inclusion criteria: 1.Patients in West China Hospital of Sichuan University from 2020 to 2022 who meet the SAP definition in the 2012 Atlanta Classification Standard for acute pancreatitis; 2. The time of receiving pancreatic surgery was within 1 week of the onset of the disease; 3. Age 18-60. Control inclusion criteria: 1. Patients who received pancreatic surgery for benign or malignant pancreatic tumors in West China Hospital of Sichuan University from 2010 to 2022; 2. Age 18-60.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic pancreatitis 2. Pregnancy/long-term oral contraceptives, glucocorticoids. 3. Incomplete clinical dat

Design outcomes

Primary

MeasureTime frame
Solute carrier family 9 member A8;—

Countries

China

Contacts

Public ContactChunhui Wang

West China Hospital of Sichuan University

wangch@scu.edu.cn+86 189 8060 2216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026